Literature DB >> 4041075

Radioimmunoassay of human sex hormone binding globulin: improved radioiodination procedure.

P Fernlund, S Gershagen, I Larsson, G Rannevik.   

Abstract

Sex hormone binding globulin (SHBG), purified by affinity chromatography from retroplacental blood plasma, was reacted with 3-(p-hydroxyphenyl) propionic acid N-hydroxysuccinimidyl ester (PHPPS, Bolton-Hunter reagent). The derivative of SHBG obtained (parahydroxyphenylpropionyl-SHBG; PHPP-SHBG) was stable and could, in contrast to underived SHBG, be efficiently 125I-iodinated with a lactoperoxidase technique. The PHPP-SHBG labelled with 125I had good antiserum binding and stability properties and was used for radioimmunoassay (RIA) of SHBG in serum. The RIA requires a total incubation time of 3 h. It has been standardized with purified SHBG and has a sensitivity of 5 micrograms/l, giving a lowest detectable concentration in the routine procedure (samples diluted 1:40) of about 0.2 mg/l. Variation within and between assay was 4.1% and 7.2%, respectively, for samples with values within the normal range. Values obtained by this RIA procedure correlate well with those obtained by a dihydrotestosterone binding method and by an electroimmunoassay technique. The mean serum concentration of SHBG in healthy, regularly menstruating women (n = 42) was 3.7 +/- 1.0 (SD, standard deviation) mg/l and in healthy men (n = 100) 2.0 +/- 0.9 mg/l.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4041075     DOI: 10.3109/00365518509155244

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  2 in total

1.  Normal pituitary hormone response to thyrotrophin and gonadotrophin releasing hormones in subjects exposed to elemental mercury vapour.

Authors:  E M Erfurth; A Schütz; A Nilsson; L Barregård; S Skerfving
Journal:  Br J Ind Med       Date:  1990-09

2.  The membrane receptor for sex steroid binding protein is not ubiquitous.

Authors:  R Frairia; N Fortunati; F Fissore; A Fazzari; P Zeppegno; L Varvello; M Orsello; L Berta
Journal:  J Endocrinol Invest       Date:  1992-09       Impact factor: 4.256

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.